{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:23:19Z","timestamp":1767979399314,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.biochi.2021.01.010","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T11:54:08Z","timestamp":1611143648000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5839-7675","authenticated-orcid":false,"given":"Mira A.M.","family":"Behnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2021.01.010_bib1","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/jvi.69.7.4331-4338.1995","article-title":"Characterization of a human coronavirus (strain 229E) 3C-like proteinase activity","volume":"69","author":"Ziebuhr","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2021.01.010_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biochi.2021.01.010_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases","volume":"27","author":"Schechter","year":"1967","journal-title":"I.\u00a0Papain. Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2021.01.010_bib4","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1073\/pnas.1601327113","article-title":"SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity","volume":"113","author":"Muramatsu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biochi.2021.01.010_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biochi.2020.04.014","article-title":"Conformational selection in the flaviviral NS2B-NS3 protease","volume":"174","author":"Behnam","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2021.01.010_bib6","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biochi.2021.01.010_bib7","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biochi.2021.01.010_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2021.01.010_bib9","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biochi.2021.01.010_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","article-title":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur","volume":"27","author":"Jin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib11","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biochi.2021.01.010_bib12","doi-asserted-by":"crossref","first-page":"31257","DOI":"10.1074\/jbc.M502577200","article-title":"Mechanism of the maturation process of SARS-CoV 3CL protease","volume":"280","author":"Hsu","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1107\/S1744309105033257","article-title":"Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer","volume":"61","author":"Xu","year":"2005","journal-title":"Acta Crystallogr. F"},{"key":"10.1016\/j.biochi.2021.01.010_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jmb.2006.11.073","article-title":"Production of authentic SARS-CoV Mpro with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction","volume":"366","author":"Xue","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/pro.76","article-title":"C-terminal domain of SARS-CoV main protease can form a 3D domain-swapped dimer","volume":"18","author":"Zhong","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.biochi.2021.01.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2012.10.053","article-title":"Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases","volume":"59","author":"Chuck","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jmb.2005.09.004","article-title":"Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide","volume":"353","author":"Lee","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jmb.2006.11.078","article-title":"Crystal structures reveal an induced-fit binding of a substrate-like aza-peptide epoxide to SARS coronavirus main peptidase","volume":"366","author":"Lee","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jmb.2005.09.012","article-title":"pH-dependent conformational flexibility of the SARS-CoV main proteinase (Mpro) dimer: molecular dynamics simulations and multiple x-ray structure analyses","volume":"354","author":"Tan","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13238-010-0044-8","article-title":"Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease","volume":"1","author":"Zhang","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.biochi.2021.01.010_bib21","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/JVI.02680-07","article-title":"Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease","volume":"82","author":"Shi","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2021.01.010_bib22","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1021\/jm200870n","article-title":"Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors","volume":"54","author":"Akaji","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib23","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1021\/bi1002585","article-title":"Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CLpro","volume":"49","author":"Barrila","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2021.01.010_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1107\/S0907444913001315","article-title":"Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease","volume":"69","author":"Wu","year":"2013","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.biochi.2021.01.010_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2009.03.034","article-title":"Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure","volume":"388","author":"Hu","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.biochi.2021.01.010_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.chembiol.2008.04.011","article-title":"A\u00a0structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters","volume":"15","author":"Verschueren","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib27","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jmb.2007.06.001","article-title":"A\u00a0mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase","volume":"371","author":"Yin","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib28","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib29","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1021\/jm050548m","article-title":"Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors","volume":"48","author":"Ghosh","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib30","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1021\/jm0603926","article-title":"Synthesis, crystal structure, structure\u2212activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor","volume":"49","author":"Yang","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib31","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/jm060207o","article-title":"Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease","volume":"49","author":"Lu","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib32","doi-asserted-by":"crossref","first-page":"8744","DOI":"10.1021\/bi0621415","article-title":"Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus","volume":"46","author":"Goetz","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2021.01.010_bib33","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1016\/j.bmcl.2007.08.031","article-title":"Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors","volume":"17","author":"Ghosh","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.biochi.2021.01.010_bib34","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1016\/j.febslet.2007.10.048","article-title":"Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors","volume":"581","author":"Lee","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biochi.2021.01.010_bib35","doi-asserted-by":"crossref","first-page":"7646","DOI":"10.1074\/jbc.M807947200","article-title":"Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds","volume":"284","author":"Lee","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1747-0285.2008.00679.x","article-title":"Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CLpro","volume":"72","author":"Bacha","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biochi.2021.01.010_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.antiviral.2011.08.001","article-title":"Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease","volume":"92","author":"Zhu","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biochi.2021.01.010_bib38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm301580n","volume":"56","author":"Jacobs","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib39","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1016\/j.bmcl.2013.08.112","article-title":"Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding","volume":"23","author":"Turlington","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.biochi.2021.01.010_bib40","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bmc.2014.12.028","article-title":"Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors","volume":"23","author":"Shimamoto","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib41","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.02114-07","article-title":"Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design","volume":"82","author":"Xue","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2021.01.010_bib42","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib43","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acs.biochem.7b01127","article-title":"Inhibitor bound dengue NS2B-NS3pro reveals multiple dynamic binding modes","volume":"57","author":"Gibbs","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2021.01.010_bib44","doi-asserted-by":"crossref","first-page":"24765","DOI":"10.1074\/jbc.M311744200","article-title":"Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme","volume":"279","author":"Shi","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1742-4658.2006.05130.x","article-title":"The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain","volume":"273","author":"Shi","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.biochi.2021.01.010_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12104-010-9287-9","article-title":"1H, 13C and 15N resonance assignments of SARS-CoV main protease N-terminal domain","volume":"5","author":"Zhang","year":"2011","journal-title":"Biomol. NMR Assign."},{"key":"10.1016\/j.biochi.2021.01.010_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pbiomolbio.2018.08.009","article-title":"Structurally- and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, dengue and Zika viruses","volume":"143","author":"Lim","year":"2019","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acscombsci.0c00058","article-title":"Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy","volume":"22","author":"Goyal","year":"2020","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.biochi.2021.01.010_bib49","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.1021\/bi061746y","article-title":"SARS CoV main proteinase: the monomer\u2212dimer equilibrium dissociation constant","volume":"45","author":"Graziano","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2021.01.010_bib50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1515\/BC.2009.065","article-title":"Subsite cooperativity in protease specificity","volume":"390","author":"Ng","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib51","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.febslet.2006.04.004","article-title":"Enzymatic activity of the SARS coronavirus main proteinase dimer","volume":"580","author":"Graziano","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biochi.2021.01.010_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1745-7254.2005.00010.x","article-title":"Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique","volume":"26","author":"Chen","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biochi.2021.01.010_bib53","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/bi036022q","article-title":"3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism","volume":"43","author":"Huang","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2021.01.010_bib54","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.biochi.2021.01.010_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virusres.2007.02.015","article-title":"Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery","volume":"133","author":"Grum-Tokars","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.biochi.2021.01.010_bib56","doi-asserted-by":"crossref","first-page":"14958","DOI":"10.1021\/bi0490237","article-title":"Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease","volume":"43","author":"Chou","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2021.01.010_bib57","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bpj.2009.12.4272","article-title":"Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease","volume":"98","author":"Cheng","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.biochi.2021.01.010_bib58","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib59","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide\u2013boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2021.01.010_bib60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nchembio.232","article-title":"The role of dynamic conformational ensembles in biomolecular recognition","volume":"5","author":"Boehr","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biochi.2021.01.010_bib61","article-title":"Mechanisms of ligand binding","volume":"1","author":"Cera","year":"2020","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.biochi.2021.01.010_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13238-010-0011-4","article-title":"Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode","volume":"1","author":"Chen","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.biochi.2021.01.010_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/prot.22223","article-title":"Selected-fit versus induced-fit protein binding: kinetic differences and mutational analysis","volume":"75","author":"Weikl","year":"2009","journal-title":"Proteins"},{"key":"10.1016\/j.biochi.2021.01.010_bib64","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1042\/BCJ20200029","article-title":"Processing of the SARS-CoV pp1a\/ab nsp7\u201310 region","volume":"477","author":"Krichel","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.biochi.2021.01.010_bib65","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/jvi.66.3.1535-1542.1992","article-title":"Cleavage of the dengue virus polyprotein at the NS3\/NS4A and NS4B\/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A\/NS4B may be processed by a cellular protease","volume":"66","author":"Cahour","year":"1992","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.biochi.2021.01.010_bib66","doi-asserted-by":"crossref","first-page":"10136","DOI":"10.1073\/pnas.1805195115","article-title":"Targeting intramolecular proteinase NS2B\/3 cleavages for trans-dominant inhibition of dengue virus","volume":"115","author":"Constant","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biochi.2021.01.010_bib67","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biochi.2021.01.010_bib68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.str.2004.02.031","article-title":"Heterogeneity and inaccuracy in protein structures solved by X-ray crystallography","volume":"12","author":"DePristo","year":"2004","journal-title":"Structure"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908421000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908421000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:19:02Z","timestamp":1759540742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908421000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":68,"alternative-id":["S0300908421000201"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2021.01.010","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2021.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}